<table id="table14" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 14. Mean Pharmacokinetic Parameters<footnote id="table14a">The majority of parameter means determined in each study had coefficients of variation between 20% and 40% for half-life and CL/F and between 30% and 70% for <sub>Tmax</sub>. The overall mean values were calculated from individual study means that were weighted based on the number of volunteers/subjects in each study. The numbers in parentheses below each parameter mean represent the range of individual volunteer/subject values across studies.</footnote> in Healthy Volunteers and Adult Subjects With Epilepsy</caption>
<col align="left" valign="top" width="31%"></col>
<col align="center" valign="top" width="15%"></col>
<col align="center" valign="top" width="18%"></col>
<col align="center" valign="top" width="18%"></col>
<col align="center" valign="top" width="18%"></col>
<thead>
<tr>
<th align="center" stylecode="Lrule Rrule" valign="middle">Adult Study Population</th>
<th stylecode="Rrule" valign="middle">Number of Subjects</th>
<th stylecode="Rrule" valign="top">T<sub>max</sub>:<br/>Time of Maximum Plasma Concentration (h)</th>
<th stylecode="Rrule" valign="top">t<sub>Â½</sub>:<br/>Elimination Half-life (h)</th>
<th stylecode="Rrule" valign="top">CL/F:<br/>Apparent Plasma Clearance (mL/min/kg)</th>
</tr>
</thead>
<tbody>
<tr>
<td stylecode="Lrule Rrule">
<content stylecode="bold">Healthy volunteers taking no other medications:</content>
</td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
</tr>
<tr>
<td stylecode="Lrule Rrule">Single-dose lamotrigine</td>
<td stylecode="Rrule">179</td>
<td stylecode="Rrule">2.2 (0.25-12.0)</td>
<td stylecode="Rrule">32.8  (14.0-103.0)</td>
<td stylecode="Rrule">0.44 (0.12-1.10)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Multiple-dose lamotrigine</td>
<td stylecode="Rrule">36</td>
<td stylecode="Rrule">1.7 (0.5-4.0)</td>
<td stylecode="Rrule">25.4 (11.6-61.6)</td>
<td stylecode="Rrule">0.58 (0.24-1.15)</td>
</tr>
<tr>
<td stylecode="Lrule Rrule">
<content stylecode="bold">Healthy volunteers taking valproate:</content>
</td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
</tr>
<tr>
<td stylecode="Lrule Rrule">Single-dose lamotrigine</td>
<td stylecode="Rrule">6</td>
<td stylecode="Rrule">1.8  (1.0-4.0)</td>
<td stylecode="Rrule">48.3  (31.5-88.6)</td>
<td stylecode="Rrule">0.30  (0.14-0.42)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Multiple-dose lamotrigine</td>
<td stylecode="Rrule">18</td>
<td stylecode="Rrule">1.9  (0.5-3.5)</td>
<td stylecode="Rrule">70.3 (41.9-113.5)</td>
<td stylecode="Rrule">0.18 (0.12-0.33)</td>
</tr>
<tr>
<td stylecode="Lrule Rrule">
<content stylecode="bold">Subjects with epilepsy taking valproate only:</content>
</td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Single-dose lamotrigine</td>
<td stylecode="Rrule">4</td>
<td stylecode="Rrule">4.8 (1.8-8.4)</td>
<td stylecode="Rrule">58.8 (30.5-88.8)</td>
<td stylecode="Rrule">0.28 (0.16-0.40)</td>
</tr>
<tr>
<td stylecode="Lrule Rrule">
<content stylecode="bold">Subjects with epilepsy taking carbamazepine, phenytoin, phenobarbital, or primidone<footnote id="table14b">Carbamazepine, phenytoin, phenobarbital, and primidone have been shown to increase the apparent clearance of lamotrigine. Estrogen-containing oral contraceptives and other drugs, such as rifampin and protease inhibitors lopinavir/ritonavir and atazanavir/ritonavir, that induce lamotrigine glucuronidation have also been shown to increase the apparent clearance of lamotrigine [<content stylecode="italics">see <linkhtml href="#S7">Drug Interactions (7)</linkhtml>
</content>]. 													</footnote> plus valproate:</content>
</td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="bottom">Single-dose lamotrigine</td>
<td stylecode="Rrule">25</td>
<td stylecode="Rrule">3.8 (1.0-10.0)</td>
<td stylecode="Rrule">27.2 (11.2-51.6)</td>
<td stylecode="Rrule">0.53 (0.27-1.04)</td>
</tr>
<tr>
<td stylecode="Lrule Rrule">
<content stylecode="bold">Subjects with epilepsy taking carbamazepine, phenytoin, phenobarbital, or primidone<footnoteref idref="table14b"></footnoteref>:</content>
</td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
</tr>
<tr>
<td stylecode="Lrule Rrule" valign="bottom">Single-dose lamotrigine</td>
<td stylecode="Rrule">24</td>
<td stylecode="Rrule">2.3 (0.5-5.0)</td>
<td stylecode="Rrule">14.4 (6.4-30.4)</td>
<td stylecode="Rrule">1.10 (0.51-2.22)</td>
</tr>
<tr>
<td stylecode="Lrule Rrule" valign="bottom">Multiple-dose lamotrigine</td>
<td stylecode="Rrule">17</td>
<td stylecode="Rrule">2.0 (0.75-5.93)</td>
<td stylecode="Rrule">12.6 (7.5-23.1)</td>
<td stylecode="Rrule">1.21 (0.66-1.82)</td>
</tr>
</tbody>
</table>